Correlates of malaria vaccine efficacy
DI Stanisic, MBB McCall - Expert Review of Vaccines, 2021 - Taylor & Francis
… efficacy against controlled human malaria infections (CHMI) and against naturally acquired
infections. Expert Opinion: Effective vaccination … disappointing efficacy of malaria vaccine …
infections. Expert Opinion: Effective vaccination … disappointing efficacy of malaria vaccine …
Malaria vaccines: progress to date
DI Stanisic, MF Good - BioDrugs, 2023 - Springer
… malaria vaccine and was shown to have modest efficacy … malaria vaccine that is able to
induce long-lasting protective … factors including the complexity of the malaria parasite’s life-cycle, …
induce long-lasting protective … factors including the complexity of the malaria parasite’s life-cycle, …
Challenges and strategies for developing efficacious and long-lasting malaria vaccines
… reducing the global malaria burden (1). … malaria vaccines with >75% efficacy against
clinical malaria and suitable for use in all malaria-endemic areas by 2030 (duration of protection …
clinical malaria and suitable for use in all malaria-endemic areas by 2030 (duration of protection …
[HTML][HTML] … of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the RTS, S malaria vaccine
S Chaudhury, RS MacGill, AM Early, JS Bolton… - Vaccine, 2021 - Elsevier
… Vaccines using a single allele may have lower efficacy … the efficacy of the CSP-based RTS,S
malaria vaccine may be … falciparum CSP alleles that diverge from the 3D7 vaccine allele, …
malaria vaccine may be … falciparum CSP alleles that diverge from the 3D7 vaccine allele, …
Seasonal malaria vaccination with or without seasonal malaria chemoprevention
D Chandramohan, I Zongo, I Sagara… - … England Journal of …, 2021 - Mass Medical Soc
… The protective efficacy of the combination as compared with the vaccine alone against these
outcomes was 59.6% (95% CI, 54.7 to 64.0), 70.6% (95% CI, 42.3 to 85.0), and 75.3% (95% …
outcomes was 59.6% (95% CI, 54.7 to 64.0), 70.6% (95% CI, 42.3 to 85.0), and 75.3% (95% …
Malaria vaccines since 2000: progress, priorities, products
PE Duffy, J Patrick Gorres - npj Vaccines, 2020 - nature.com
… Protective efficacy of PEV was first demonstrated in a human in the 1970s using radiation-attenuated
WSV delivered through hundreds of mosquito bites; the vaccinee was protected …
WSV delivered through hundreds of mosquito bites; the vaccinee was protected …
Malaria vaccines: a new era of prevention and control
… that prioritizes malaria vaccine … vaccines might improve upon the protective efficacy of RTS,S
or R21 for children, or address the wider malaria scourge by preventing pregnancy malaria, …
or R21 for children, or address the wider malaria scourge by preventing pregnancy malaria, …
Novel malaria vaccines
MB Laurens - Human Vaccines & Immunotherapeutics, 2021 - Taylor & Francis
… The RTS,S/AS01 malaria vaccine provides moderate efficacy and is … malaria vaccines,
including novel approaches that build on principles learned from RTS,S development, vaccination …
including novel approaches that build on principles learned from RTS,S development, vaccination …
RTS, S: the first malaria vaccine
F Zavala - The Journal of clinical investigation, 2022 - Am Soc Clin Investig
… , and the estimated protective efficacy was 29% by proportional analysis (11). A recent trial
of this attenuated sporozoite vaccine in Kenya failed to demonstrate significant efficacy in 5- …
of this attenuated sporozoite vaccine in Kenya failed to demonstrate significant efficacy in 5- …
Randomized clinical trial to assess the protective efficacy of a Plasmodium vivax CS synthetic vaccine
M Arévalo-Herrera, X Gaitán, M Larmat-Delgado… - Nature …, 2022 - nature.com
… most advanced malaria vaccine candidate with a mean efficacy of ~… malaria vaccine among
children in sub-Saharan Africa and other regions with moderate to high P. falciparum malaria …
children in sub-Saharan Africa and other regions with moderate to high P. falciparum malaria …
相关搜索
- malaria vaccine development
- as01 malaria vaccine
- malaria vaccine trials efficacy and immunogenicity
- as02a malaria vaccine duration of protection
- malaria vaccine seven year efficacy
- malaria vaccine efficacy and safety
- blood stage malaria vaccines
- malaria vaccine technology roadmap
- plasmodium falciparum malaria vaccines
- pre-erythrocytic malaria vaccines
- plasmodium vivax malaria vaccine candidate
- sporozoite malaria vaccine
- first malaria vaccine
- malaria vaccines human challenge models
- malaria vaccine main barriers
- malaria vaccines 60 year journey